Got A Tip?

Star Seeker

Headline of the Week

Headline Of The Week Weak


New Vaginal Gel Stops AIDS Virus
Cosmetic Ingredient GML Protects Monkeys From AIDS Virus

Inneresting development! CLICK HERE to read the article accompanying this headline.

New Vaginal Gel Stops AIDS Virus
Cosmetic Ingredient GML Protects Monkeys From AIDS Virus
A new kind of vaginal gel prevents sexual transmission of the AIDS virus in monkey studies.
The anti-HIV ingredient in the gel is glycerol monolaurate or GML. It’s already FDA approved as an ingredient in cosmetics and medicines.
“The results are very encouraging. They point to a novel avenue to prevent sexual transmission of HIV,” study researcher Ashley T. Haase, MD, head of the microbiology department at the University of Minnesota, Minneapolis, said at a telephone news conference.
The surprise finding that GML can block HIV comes from basic research showing that the AIDS virus gains a foothold in the vagina by taking advantage of the body’s immune system. Immune responses to the virus draw T cells — the white blood cells HIV loves to infect — to the site of infection. Without T-cell recruitment, HIV loses its grip.
That’s where GML comes in. The antimicrobial agent affects immune responses and breaks the chain of events that let HIV spread through the body.
“We thought if we could modulate the immune response at the portal of HIV entry, we could block sexual transmission,” Haase said. “[Colleague] Patrick Schlievert’s work with GML showed that it had many properties that might block HIV expansion and systematic spread.”
Haase, Schlievert, and colleagues gave five rhesus macaque monkeys daily GML treatments before putting 200 infectious doses of deadly SIV — the monkey version of HIV — into their vaginas. Another four animals got a gel without GML.
The four animals not given GML got AIDS. Those treated with GML showed no sign of infection during the short-term study, although one of the five animals showed signs of infection several months later. But just as HIV drugs with different modes of action are more effective when mixed into a drug “cocktail,” Haase says GML could be mixed with different kinds of anti-HIV agents.
“GML could be part of a combined strategy with another vaginal microbicide, such as PRO 2000, with a different mechanism of action,” he suggests.
Ingredients of GML Anti-HIV Gel in Common Use
GML is found in breast milk, Schlievert says, and it is used in many cosmetics and in medicines taken orally or used on the skin. And recent studies show that GML kills many different kinds of germs — including vaginal yeast infections and several different sexually transmitted diseases, said Schlievert, professor of microbiology at the University of Minnesota.
“GML is presently being considered as an additive to tampons because of its ability to interfere with bacterial growth, including the bacteria that cause toxic shock syndrome,” Schlievert said at the news conference.
For vaginal use in the monkey studies — and with an eye toward future human use — GML was mixed with KY Warming Liquid, an over-the-counter product widely used as a personal lubricant.
“What was done was to combine two FDA-approved medical devices to create another approved device,” Schlievert said.
However, Schlievert said GML has not yet been tested for long-term human use.
And there’s a lot more work to do with monkeys before GML gel is ready for human tests. That will have to be done before human studies of GML gel for HIV prevention.
Haase, Schlievert, and colleagues report their findings in the March 4 online edition of the journal Nature.

Related Posts

Mar 12, 2009 15:55pm PDT

Share This